Interleukin-10 protects neonatal mice from lethal group B streptococcal infection.
about
Increased Risk of Group B Streptococcus Invasive Infection in HIV-Exposed but Uninfected Infants: A Review of the Evidence and Possible MechanismsInduction and termination of inflammatory signaling in group B streptococcal sepsis.Inhibition of IL-10 production by maternal antibodies against Group B Streptococcus GAPDH confers immunity to offspring by favoring neutrophil recruitmentRegulatory role of interleukin-10 in experimental group B streptococcal arthritis.Soluble mediators regulating immunity in early lifeInteraction of Streptococcus agalactiae and Cellular Innate Immunity in Colonization and DiseaseEndotoxin-induced lethality in neonatal mice is counteracted by interleukin-10 (IL-10) and exacerbated by anti-IL-10Interleukin-18 is an essential element in host resistance to experimental group B streptococcal disease in neonates.Group B Streptococcus Induces a Robust IFN-γ Response by CD4(+) T Cells in an In Vitro and In Vivo ModelComparison of the susceptibilities of C57BL/6 and A/J mouse strains to Streptococcus suis serotype 2 infection.Mechanism of T-cell mediated protection in newborn mice against a Chlamydia infection.Aging and human CD4(+) regulatory T cells.Neonatal Group B Streptococcal Disease in Otherwise Healthy Infants: Failure of Specific Neonatal Immune ResponsesHuman monocyte receptors involved in tumor necrosis factor responses to group B streptococcal products.Role of interleukin 12 in experimental neonatal sepsis caused by group B streptococci.Soluble antigens from group B streptococci induce cytokine production in human blood cultures.Combination therapy with ampicillin and azithromycin improved outcomes in a mouse model of group B streptococcal sepsis.Group B Streptococci Induce Proinflammatory Responses via a Protein Kinase D1-Dependent Pathway.IL-10 up-regulates nitric oxide (NO) synthesis by lipopolysaccharide (LPS)-activated macrophages: improved control of Trypanosoma cruzi infection.Increased weight loss with reduced viral replication in interleukin-10 knock-out mice infected with murine cytomegalovirus.
P2860
Q28067423-97635F0A-953C-4B06-B738-406A6956921AQ33608933-26402095-8057-48BA-A25C-0F2E276D586FQ34082651-C165045F-6A74-4CD3-AA88-1EFBD4044B8CQ34123507-958BE918-CE27-400D-BEFB-6A9C6698E565Q34238426-4CD5EC5A-2830-4062-A098-F9A59023BF73Q34419556-8D01AA64-A304-4CF9-9BAC-205E9B231B79Q35231052-95F57B24-2102-418A-A42E-B5A23EC4E449Q36228875-F8601A15-F25D-4E65-B04D-2AAC6267E2A1Q36632936-0540F030-ECD1-4C13-B637-55AEE47B9E5AQ36845138-729D59C0-B0FD-4B0A-9E95-643CD959DDE0Q37326852-6D5DDD76-9928-44F9-8593-41D327459779Q37367142-2CBBD767-ED9E-4EC6-B6B8-6075C83D3EE6Q37683149-BBE16075-D8F0-4B7C-A9AF-694F336BAAE8Q39514295-E30DC83C-71DB-496B-B436-F66C12E309A6Q39830920-E2BEB5A5-66DE-4AAB-8BDA-6F592B140B7FQ39831101-60549BAD-6AAC-4DD7-A337-39987121FF11Q40113070-ABA2A3F7-C46E-471F-8961-EA37F15372ABQ40230584-14279814-145F-4FD3-B00F-D9325DD2D4C8Q41017961-0F9C51C1-1A52-44F8-90A6-79235F189CEAQ47261209-290ADBB0-4403-4FA8-BDEE-092971F1B800
P2860
Interleukin-10 protects neonatal mice from lethal group B streptococcal infection.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
Interleukin-10 protects neonatal mice from lethal group B streptococcal infection.
@en
Interleukin-10 protects neonatal mice from lethal group B streptococcal infection.
@nl
type
label
Interleukin-10 protects neonatal mice from lethal group B streptococcal infection.
@en
Interleukin-10 protects neonatal mice from lethal group B streptococcal infection.
@nl
prefLabel
Interleukin-10 protects neonatal mice from lethal group B streptococcal infection.
@en
Interleukin-10 protects neonatal mice from lethal group B streptococcal infection.
@nl
P2093
P2860
P1476
Interleukin-10 protects neonatal mice from lethal group B streptococcal infection
@en
P2093
P2860
P304
P407
P577
1996-07-01T00:00:00Z